NOCIL
|
NOCIL Last 5 Year Financial Ratios History
[Consolidated]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Operational & Financial Ratios | |||||
| Earnings Per Share (Rs) | 7.98 | 8.95 | 10.57 | 5.32 | 7.89 |
| CEPS(Rs) | 11.15 | 12.29 | 13.47 | 7.57 | 9.93 |
| DPS(Rs) | 3.00 | 3.00 | 3.00 | 2.00 | 2.50 |
| Book NAV/Share(Rs) | 101.53 | 92.80 | 86.48 | 76.96 | 71.22 |
| Tax Rate(%) | 26.11 | 26.20 | 26.81 | 17.47 | 14.22 |
| Margin Ratios | |||||
| Core EBITDA Margin(%) | 13.50 | 15.63 | 18.21 | 14.15 | 21.06 |
| EBIT Margin(%) | 12.57 | 12.58 | 15.38 | 11.69 | 18.16 |
| Pre Tax Margin(%) | 12.46 | 12.50 | 15.31 | 11.59 | 18.00 |
| PAT Margin (%) | 9.21 | 9.23 | 11.21 | 9.56 | 15.44 |
| Cash Profit Margin (%) | 12.86 | 12.67 | 14.28 | 13.61 | 19.43 |
| Performance Ratios | |||||
| ROA(%) | 6.87 | 8.09 | 10.22 | 5.78 | 9.06 |
| ROE(%) | 8.21 | 9.99 | 12.95 | 7.19 | 11.18 |
| ROCE(%) | 11.17 | 13.56 | 17.71 | 8.75 | 13.09 |
| Asset Turnover(x) | 0.75 | 0.88 | 0.91 | 0.60 | 0.59 |
| Sales/Fixed Asset(x) | 1.14 | 1.31 | 1.31 | 0.84 | 0.90 |
| Working Capital/Sales(x) | 1.78 | 2.28 | 2.69 | 2.24 | 2.97 |
| Efficiency Ratios | |||||
| Fixed Capital/Sales(x) | 0.88 | 0.77 | 0.76 | 1.20 | 1.11 |
| Receivable days | 86.68 | 89.84 | 88.08 | 101.01 | 93.89 |
| Inventory Days | 64.13 | 69.73 | 57.89 | 59.62 | 66.23 |
| Payable days | 41.66 | 52.57 | 57.73 | 71.68 | 71.00 |
| Valuation Parameters | |||||
| PER(x) | 31.24 | 23.05 | 23.59 | 32.83 | 8.34 |
| PCE(x) | 22.36 | 16.78 | 18.51 | 23.06 | 6.63 |
| Price/Book(x) | 2.46 | 2.22 | 2.88 | 2.27 | 0.92 |
| Yield(%) | 1.20 | 1.45 | 1.20 | 1.15 | 3.80 |
| EV/Net Sales(x) | 2.81 | 2.09 | 2.63 | 3.05 | 1.27 |
| EV/Core EBITDA(x) | 17.32 | 13.05 | 14.27 | 19.39 | 5.74 |
| EV/EBIT(x) | 22.35 | 16.63 | 17.12 | 26.10 | 7.00 |
| EV/CE(x) | 2.39 | 2.18 | 2.86 | 2.20 | 0.91 |
| M Cap / Sales | 2.88 | 2.13 | 2.64 | 3.14 | 1.29 |
| Growth Ratio | |||||
| Net Sales Growth(%) | -10.63 | 2.88 | 69.93 | 9.26 | -18.85 |
| Core EBITDA Growth(%) | -9.49 | -10.72 | 99.31 | -22.34 | -38.09 |
| EBIT Growth(%) | -10.66 | -15.90 | 123.60 | -29.65 | -44.80 |
| PAT Growth(%) | -10.83 | -15.31 | 99.20 | -32.34 | -29.31 |
| EPS Growth(%) | -10.83 | -15.34 | 98.78 | -32.59 | -29.39 |
| Financial Stability Ratios | |||||
| Total Debt/Equity(x) | - | - | - | - | - |
| Current Ratio(x) | 5.89 | 5.15 | 3.26 | 2.96 | 3.03 |
| Quick Ratio(x) | 4.55 | 3.49 | 1.97 | 2.17 | 2.06 |
| Interest Cover(x) | 112.10 | 169.41 | 221.75 | 111.44 | 116.41 |
| Total Debt/Mcap(x) | - | - | - | - | - |
Compare Financial Ratios of peers of NOCIL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NOCIL | ₹4,089.0 Cr | -6.3% | -6.9% | -3.4% | Stock Analytics | |
| PIDILITE INDUSTRIES | ₹151,055.0 Cr | -2.9% | -0.6% | 14.1% | Stock Analytics | |
| SOLAR INDUSTRIES INDIA | ₹92,098.1 Cr | -1.5% | 1.8% | 48.6% | Stock Analytics | |
| SRF | ₹67,451.5 Cr | 0.3% | 2.4% | -3.6% | Stock Analytics | |
| GUJARAT FLUOROCHEMICALS | ₹47,726.0 Cr | 0.6% | 12.1% | 28.9% | Stock Analytics | |
| DEEPAK NITRITE | ₹35,413.8 Cr | -1.4% | -3.8% | 17.1% | Stock Analytics | |
NOCIL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NOCIL | -6.3% |
-6.9% |
-3.4% |
| SENSEX | -2.7% |
-0.8% |
9.9% |
You may also like the below Video Courses
